Skip to main content
KOBO BIOTECH LIMITED logo

KOBO BIOTECH LIMITED — Investor Relations & Filings

Ticker · 531541 ISIN · INE881A01015 BSE.NS Manufacturing
Open in API
Filings indexed 2 across all filing types
Latest filing 2026-05-13 Regulatory Filings
Country IN India
Listing BSE.NS 531541

About KOBO BIOTECH LIMITED

http://www.kobobiotech.com

Kobo Biotech Limited is a specialized enterprise focused on the manufacturing and distribution of bulk drugs, pharmaceutical intermediates, and specialty chemicals. The company engages in the research, development, and production of chemical compounds used across various industrial and medical applications. Its core operations involve the synthesis of complex molecules and the provision of raw materials for the pharmaceutical sector. Kobo Biotech emphasizes quality control and process innovation to meet the evolving demands of the global market. The firm maintains a portfolio of products designed for therapeutic and industrial utility, leveraging technical expertise in chemical engineering and biotechnology to deliver standardized solutions for its clientele.

Recent filings

Filing Released Lang Actions
Spacific features and deatils pf the resolution Plan as apprpved by the NCLT
Regulatory Filings Classification · 87% confidence The document is a formal disclosure submitted to the BSE under SEBI LODR Regulation 30 regarding the details of a CIRP resolution plan approved by the NCLT. It does not contain full financial statements or constitute an annual/interim report, earnings release, or investor presentation, but rather is a compliance announcement of a material event (resolution plan approval) under listing regulations. Such SEBI Listing Obligation disclosures fall under general regulatory filings (fallback category).
2026-05-13 English
Approval of Resolution Plan and receipt of Order from NCLT
Regulatory Filings Classification · 82% confidence The document is a formal submission to the stock exchange (BSE) under SEBI (LODR) Regulation 30, enclosing the NCLT order approving a corporate insolvency resolution plan and its synopsis. It is a regulatory disclosure of a material event (approval of a resolution plan), not the report itself (e.g., not a financial statement, annual report, or M&A deal document), and does not fall cleanly into any specialized category such as earnings release, director dealings, or share issue. Accordingly, it should be classified as a general regulatory filing (RNS).
2026-05-11 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.